Your browser doesn't support javascript.
loading
Assessing the impact of AGS-004, a dendritic cell-based immunotherapy, and vorinostat on persistent HIV-1 Infection.
Gay, Cynthia L; Kuruc, Joann D; Falcinelli, Shane D; Warren, Joanna A; Reifeis, Sarah A; Kirchherr, Jennifer L; James, Katherine S; Dewey, Morgan G; Helms, Alyson; Allard, Brigitte; Stuelke, Erin; Gamble, Alicia; Plachco, Ana; Gorelick, Robert J; Eron, Joseph J; Hudgens, Michael; Garrido, Carolina; Goonetilleke, Nilu; DeBenedette, Mark A; Tcherepanova, Irina Y; Nicolette, Charles A; Archin, Nancie M; Margolis, David M.
Afiliação
  • Gay CL; University of North Carolina HIV Cure Center, UNC Institute of Global Health and Infectious Diseases, Chapel Hill, NC, United States.
  • Kuruc JD; Department of Medicine, UNC Chapel Hill School of Medicine, Chapel Hill, NC, United States.
  • Falcinelli SD; University of North Carolina HIV Cure Center, UNC Institute of Global Health and Infectious Diseases, Chapel Hill, NC, United States.
  • Warren JA; Department of Medicine, UNC Chapel Hill School of Medicine, Chapel Hill, NC, United States.
  • Reifeis SA; University of North Carolina HIV Cure Center, UNC Institute of Global Health and Infectious Diseases, Chapel Hill, NC, United States.
  • Kirchherr JL; Department of Microbiology and Immunology, UNC Chapel Hill School of Medicine, Chapel Hill, NC, United States.
  • James KS; University of North Carolina HIV Cure Center, UNC Institute of Global Health and Infectious Diseases, Chapel Hill, NC, United States.
  • Dewey MG; Department of Microbiology and Immunology, UNC Chapel Hill School of Medicine, Chapel Hill, NC, United States.
  • Helms A; Department of Biostatistics, UNC Chapel Hill Gillings School of Public Health, Chapel Hill, NC, United States.
  • Allard B; University of North Carolina HIV Cure Center, UNC Institute of Global Health and Infectious Diseases, Chapel Hill, NC, United States.
  • Stuelke E; University of North Carolina HIV Cure Center, UNC Institute of Global Health and Infectious Diseases, Chapel Hill, NC, United States.
  • Gamble A; University of North Carolina HIV Cure Center, UNC Institute of Global Health and Infectious Diseases, Chapel Hill, NC, United States.
  • Plachco A; University of North Carolina HIV Cure Center, UNC Institute of Global Health and Infectious Diseases, Chapel Hill, NC, United States.
  • Gorelick RJ; Department of Medicine, UNC Chapel Hill School of Medicine, Chapel Hill, NC, United States.
  • Eron JJ; University of North Carolina HIV Cure Center, UNC Institute of Global Health and Infectious Diseases, Chapel Hill, NC, United States.
  • Hudgens M; University of North Carolina HIV Cure Center, UNC Institute of Global Health and Infectious Diseases, Chapel Hill, NC, United States.
  • Garrido C; Argos Therapeutics, Durham, North Carolina, USA.
  • Goonetilleke N; Argos Therapeutics, Durham, North Carolina, USA.
  • DeBenedette MA; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, United States.
  • Tcherepanova IY; University of North Carolina HIV Cure Center, UNC Institute of Global Health and Infectious Diseases, Chapel Hill, NC, United States.
  • Nicolette CA; Department of Medicine, UNC Chapel Hill School of Medicine, Chapel Hill, NC, United States.
  • Archin NM; Department of Epidemiology, UNC Chapel Hill Gillings School of Public Health, Chapel Hill, NC, United States.
  • Margolis DM; Department of Biostatistics, UNC Chapel Hill Gillings School of Public Health, Chapel Hill, NC, United States.
Sci Rep ; 10(1): 5134, 2020 03 20.
Article em En | MEDLINE | ID: mdl-32198428

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Células Dendríticas / Infecções por HIV / Imunoterapia Adotiva / HIV-1 / Inibidores de Histona Desacetilases / Vorinostat Tipo de estudo: Prognostic_studies Limite: Adult / Humans / Male / Middle aged Idioma: En Revista: Sci Rep Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Células Dendríticas / Infecções por HIV / Imunoterapia Adotiva / HIV-1 / Inibidores de Histona Desacetilases / Vorinostat Tipo de estudo: Prognostic_studies Limite: Adult / Humans / Male / Middle aged Idioma: En Revista: Sci Rep Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos